EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Higher epicardial adipose tissue volume is associated with higher coronary fatty plaque volume and is regulated by waist circumference but not EPA+DHA supplementation

Maral Amangurbanova, Ralph Daher, Abdul Aziz Asbeutah, Bhavya Vemuri, Hasan Mirza, Smaha Waseem, Abdulaziz Malik, Francine K Welty

Journal of Clinical Lipidology · 2024

DOI: 10.1016/j.jacl.2024.06.006 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Lipidology, 2024. Verfasst von Maral Amangurbanova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, United States (Drs Amangurbanova, Asbeutah, Vem…. Hauptthemen laut MEDLINE: Eicosapentaenoic Acid, Adipose Tissue, Docosahexaenoic Acids, Dietary Supplements. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: NHLBI NIH HHS, NCATS NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) supplementation lower triglyceride levels. The impact on epicardial adipose tissue volume (EATV), which is associated with cardiovascular events, is unclear. OBJECTIVE: To determine if triglyceride reduction with EPA+DHA supplementation decreases EATV and whether EATV affects coronary plaque. METHODS: 139 subjects with coronary artery disease (CAD) on statins were randomized to 3.36 g EPA+DHA daily or none (control) for 30 months. EATV, coronary plaque volumes and coronary artery calcium score were measured with coronary computed tomographic angiography. RESULTS: Change in triglyceride level correlated with change in EATV (r=0.236; p=0.006). Despite a 6.7% triglyceride reduction (p=0.021) with EPA+DHA supplementation compared to no change in control (between group p=0.034); both groups had similar reductions in EATV possibly due to statin treatment. EATV above the median (>115.6 cm3) was the only determinant of baseline coronary fatty plaque volume (β=2.4, p=0.010). After multivariate adjustment, waist circumference, a surrogate of abdominal visceral adiposity, was the only determinant of baseline EATV (odds ratio {OR]:1.093; 95% confidence interval [CI]:1.003-1.192, p=0.042). Moreover, increase in waist circumference was the only predictor of an increase in EATV at 30 months (β=0.320, p=0.018). CONCLUSIONS: EATV is associated with higher coronary fatty plaque volume and is regulated by waist circumference but not EPA+DHA supplementation at 30-month follow-up in CAD patients on statin treatment. The direct correlation between waist circumference and EATV suggests that maintaining a healthy weight may limit EATV and coronary fatty plaque volume, potentially leading to a decrease in cardiovascular events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Eicosapentaenoic AcidAdipose TissueDocosahexaenoic AcidsDietary SupplementsWaist CircumferenceCoronary Artery DiseasePlaque, AtheroscleroticPericardiumHumansMaleFemaleMiddle AgedAgedTriglyceridesEpicardial Adipose Tissue

Stichwörter der Autor:innen

Coronary artery calcium scoreCoronary computed tomographic angiographyCoronary fatty plaqueEpicardial adipose tissueOmega-3 fatty acids

Substanzen

Eicosapentaenoic AcidDocosahexaenoic AcidsTriglycerides

Autor:innen und Institutionen

  • Division of Cardiology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, United States (Drs Amangurbanova, Asbeutah, Vemuri, Mirza, Waseem, Malik, Welty).
  • Cooper University Healthcare, Camden, NJ, United States (Dr Daher).
  • Division of Cardiology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, United States (Drs Amangurbanova, Asbeutah, Vemuri, Mirza, Waseem, Malik, Welty). Electronic address: francinewelty@g…

Förderung

  • NHLBI NIH HHS
  • NCATS NIH HHS
  • NIH

Zitieren

APA

Amangurbanova, M., Daher, R., Asbeutah, A. A., Vemuri, B., Mirza, H., Waseem, S., Malik, A., & Welty, F. K. (2024). Higher epicardial adipose tissue volume is associated with higher coronary fatty plaque volume and is regulated by waist circumference but not EPA+DHA supplementation. Journal of Clinical Lipidology. https://doi.org/10.1016/j.jacl.2024.06.006

Vancouver

Amangurbanova M, Daher R, Asbeutah AA, Vemuri B, Mirza H, Waseem S, et al. Higher epicardial adipose tissue volume is associated with higher coronary fatty plaque volume and is regulated by waist circumference but not EPA+DHA supplementation. Journal of Clinical Lipidology. 2024. doi:10.1016/j.jacl.2024.06.006

BibTeX
@article{Amangurbanova2024,
  author = {Amangurbanova, Maral and Daher, Ralph and Asbeutah, Abdul Aziz and Vemuri, Bhavya and Mirza, Hasan and Waseem, Smaha and Malik, Abdulaziz and Welty, Francine K},
  title = {Higher epicardial adipose tissue volume is associated with higher coronary fatty plaque volume and is regulated by waist circumference but not EPA+DHA supplementation},
  journal = {Journal of Clinical Lipidology},
  year = {2024},
  doi = {10.1016/j.jacl.2024.06.006}
}
Kostenlos starten →